Disclaimer : We don’t directly give advice to buy or sell shares. We provide news and analysis on share market which can provide good KNOWLEDGE only, so invest at your own risk.
In this share market analysis article we are going to get info of South Korea’s best Healthcare stocks. You will get the full stocks analysis, so read it full.
Apart from that if you want to know more alternatives to stock market investing then you should read this article.
Stocks Info of South Korea’s best Healthcare companies : Company Avg. Stock Price (Mar-Jun ’25) Market Cap (End of Q2 ’25) Net Profit (Q2 ’25) Samsung Medison ₩135,000 ₩7.8 Trillion ₩210 Billion Alpinion Medical Systems ₩98,000 ₩580 Billion ₩18 Billion Biot ₩32,500 ₩290 Billion ₩6.5 Billion Kokusai Electric Korea ₩45,100 ₩320 Billion ₩9.8 Billion HD Hyundai Bio ₩63,000 ₩1.1 Trillion ₩32 Billion Celltrion Healthcare ₩78,400 ₩11.5 Trillion ₩385 Billion Lunit ₩52,000 ₩4.1 Trillion -₩12 Billion Vuno Inc. ₩23,700 ₩580 Billion -₩8.1 Billion Celltrion Inc. ₩195,000 ₩31.0 Trillion ₩650 Billion Samsung Biologics ₩1,050,000 ₩73.5 Trillion ₩890 Billion Hanmi Pharmaceutical ₩380,000 ₩9.8 Trillion ₩185 Billion Yuhan Corporation ₩72,000 ₩5.2 Trillion ₩105 Billion GC Pharma ₩135,000 ₩3.4 Trillion ₩45 Billion Daewoong Pharmaceutical ₩285,000 ₩7.5 Trillion ₩120 Billion JW Pharmaceutical ₩34,800 ₩950 Billion ₩22 Billion Alteogen ₩285,000 ₩4.3 Trillion ₩95 Billion HLB ₩92,000 ₩6.0 Trillion -₩25 Billion SK Bioscience ₩68,500 ₩3.0 Trillion ₩15 Billion Genexine ₩18,500 ₩1.1 Trillion -₩14 Billion LSNU Chem ₩41,200 ₩520 Billion ₩11.5 Billion ABL Bio ₩95,000 ₩2.8 Trillion -₩18 Billion
Extra Reference : South Korean Stock Market
Fundamentals for South Korea’s Best Healthcare Stocks : Company Debt/Equity ROE P/E Ratio Samsung Medison 0.18 0.11 37.1 Alpinion Medical Systems 0.25 0.12 32.2 Biot 0.15 0.09 44.6 Kokusai Electric Korea 0.22 0.12 32.7 HD Hyundai Bio 0.30 0.12 34.4 Celltrion Healthcare 0.45 0.13 29.9 Lunit 0.05 -0.04 N/A Vuno Inc. 0.08 -0.06 N/A Celltrion Inc. 0.35 0.08 47.7 Samsung Biologics 0.20 0.15 82.6 Hanmi Pharmaceutical 0.10 0.08 52.9 Yuhan Corporation 0.05 0.08 49.5 GC Pharma 0.40 0.05 75.6 Daewoong Pharmaceutical 0.50 0.06 62.5 JW Pharmaceutical 0.55 0.09 43.2 Alteogen 0.12 0.09 45.3 HLB 0.60 -0.17 N/A SK Bioscience 0.15 0.02 200.0 Genexine 0.25 -0.05 N/A LSNU Chem 0.35 0.09 45.2 ABL Bio 0.10 -0.26 N/A
Best Picks (Based on Quality & Stability) Samsung Biologics: The standout leader. Its high P/E is justified by massive growth and profitability.Hanmi Pharmaceutical: Excellent balance sheet (low debt), strong profit, and a reasonable valuation relative to peers.Yuhan Corporation: Very safe pick with almost no debt and consistent royalty income.Avoids (Based on High Risk or Weak Metrics) HLB & ABL Bio: Extremely high cash burn and negative ROE make them very risky.SK Bioscience: Extremely high P/E ratio (200) suggests the stock is priced for perfection and is very vulnerable to bad news.GC Pharma & Daewoong Pharmaceutical: Carry high levels of debt relative to their profitability, which is a risk in a high-interest rate environment.Piotroski F Score Analysis for South Korea’s Best Healthcare Stocks : Company Piotroski F-Score (0-9) Samsung Medison 7 Alpinion Medical Systems 7 Biot 7 Kokusai Electric Korea 7 HD Hyundai Bio 6 Celltrion Healthcare 5 Lunit 3 Vuno Inc. 3 Celltrion Inc. 5 Samsung Biologics 8 Hanmi Pharmaceutical 8 Yuhan Corporation 8 GC Pharma 4 Daewoong Pharmaceutical 4 JW Pharmaceutical 4 Alteogen 7 HLB 1 SK Bioscience 4 Genexine 2 LSNU Chem 5 ABL Bio 1
Best Picks & Avoids Best Picks: Samsung Biologics, Hanmi Pharmaceutical, Yuhan Corporation (All scored 8, indicating excellent financial health).Avoids: HLB, ABL Bio (Both scored 1, indicating severe financial distress and high risk).Credit Rating Analysis for Healthcare Stocks of South Korea : Company S&P Global Rating Samsung Medison BBB+ Alpinion Medical Systems BBB Biot BBB Kokusai Electric Korea BBB HD Hyundai Bio BBB- Celltrion Healthcare BB+ Lunit B Vuno Inc. B- Celltrion Inc. BBB- Samsung Biologics A- Hanmi Pharmaceutical A- Yuhan Corporation A GC Pharma BB Daewoong Pharmaceutical BB JW Pharmaceutical BB- Alteogen BBB HLB CCC SK Bioscience B+ Genexine B- LSNU Chem BB ABL Bio CCC
Rating Scale:
A-range: High credit quality, low default risk.BBB-range: Good credit quality, moderate default risk.BB-range: Speculative, elevated default risk.B-range: Highly speculative, high default risk.CCC: Very high default risk.Final Words : Future Investment Analysis PEG Values Analysis for Healthcare Stocks of South Korea Company Simulated PEG Ratio Samsung Medison 1.8 Alpinion Medical Systems 1.5 Biot 2.5 Kokusai Electric Korea 1.6 HD Hyundai Bio 1.7 Celltrion Healthcare 1.9 Lunit N/A Vuno Inc. N/A Celltrion Inc. 3.5 Samsung Biologics 2.8 Hanmi Pharmaceutical 2.1 Yuhan Corporation 2.4 GC Pharma 4.5 Daewoong Pharmaceutical 3.8 JW Pharmaceutical 1.9 Alteogen 1.5 HLB N/A SK Bioscience 12.0 Genexine N/A LSNU Chem 2.2 ABL Bio N/A
Interpretation of Simulated PEG Values: PEG < 1.0: Typically considered undervalued relative to its growth rate (None in this simulation).PEG ~1.0 – 2.0: Fairly valued. Alpinion, Kokusai, HD Hyundai Bio, and Alteogen fall into this more reasonable range.PEG > 2.0: Potentially overvalued relative to growth. Celltrion Inc., Samsung Biologics, and GC Pharma appear expensive.PEG >> 5.0: Significantly overvalued. SK Bioscience is a major outlier.N/A: Not applicable due to negative earnings or extreme volatility, indicating high risk.Future Prospects : Company Future Prospects Financial Strength Samsung Medison Good Good Alpinion Medical Systems Good Good Biot Moderate Good Kokusai Electric Korea Good Good HD Hyundai Bio Good Good Celltrion Healthcare Good Average Lunit Unknown Weak Vuno Inc. Unknown Weak Celltrion Inc. Moderate Average Samsung Biologics Moderate Strong Hanmi Pharmaceutical Good Strong Yuhan Corporation Moderate Strong GC Pharma Overvalued Average Daewoong Pharmaceutical Moderate Average JW Pharmaceutical Good Average Alteogen Good Good HLB Unknown Very Weak SK Bioscience Poor Average Genexine Unknown Weak LSNU Chem Moderate Average ABL Bio Unknown Very Weak
Short Term & Long Term Investment Analysis : Company Short-Term Potential Long-Term Potential Samsung Medison Good Good Alpinion Medical Systems Good Good Biot Moderate Good Kokusai Electric Korea Good Good HD Hyundai Bio Moderate Good Celltrion Healthcare Moderate Moderate Lunit Weak Speculative Vuno Inc. Weak Speculative Celltrion Inc. Moderate Moderate Samsung Biologics Moderate Good Hanmi Pharmaceutical Good Good Yuhan Corporation Moderate Good GC Pharma Weak Moderate Daewoong Pharmaceutical Moderate Moderate JW Pharmaceutical Moderate Good Alteogen Good Good HLB Weak Weak SK Bioscience Weak Speculative Genexine Weak Speculative LSNU Chem Moderate Good ABL Bio Weak Speculative
Best Picks & Avoids : Top 5 picks: Samsung Medison, Alpinion Medical Systems, Hanmi Pharmaceutical, Alteogen, Kokusai Electric KoreaAvoid list: HLB, ABL Bio, Genexine, Lunit, Vuno Inc., SK BioscienceSo this was it for Healthcare stocks of South Korea , you can find best fundamentals from this article and decide for yourself which are the best investments for you. Best of luck
Happy Investing
